MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

500913

Report Date :

06.04.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

GEMINI INDUSTRIA DE INSUMOS FARMACEUTICOS LTDA

 

 

Registered Office :

Rua VP 4D - S/Nº, Quadra,8 -A - Módulos I E Ii - Distrito Agroindustrial De Anápolis, 75132-105 - Anápolis/Go

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2016

 

 

Date of Incorporation :

23.01.2009

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacture, Import and Distribution of Pharmaceutical Products.

 

 

No. of Employees :

160

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

 

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Good

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

                Previous Rating               

(30.09.2017)

Current Rating

(31.12.2017)

Brazil

A2

A2

 

Risk Category

 

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Brazil is the eighth-largest economy in the world, but is recovering from a recession in 2015 and 2016 that ranks as the worst in the country’s history. Falling commodity prices reduced export revenues and investment, which weakened the Brazilian real and cut tax revenues. The weaker real made existing public debt, which was largely denominated in foreign currency, more expensive. Lower tax revenues strained the government budget.

 

Economic reforms, proposed in 2016, aim to slow the growth of government spending and reduce barriers to foreign investment. Government spending growth helped to push public debt to 78% of GDP at the end of 2017, up from 50% in 2012. Policies to strengthen Brazil’s workforce and industrial sector, such as local content requirements, may have boosted employment at the expense of investment.

 

Former President Dilma ROUSSEFF was impeached and convicted in August 2016 for moving funds among government budgets; the economy has also been affected by multiple corruption scandals involving private companies and government officials. Sanctions against the firms involved — some of the largest in Brazil — has limited their business opportunities, producing a ripple effect on associated businesses and contractors. In addition, investment in these companies has declined because of the scandals.

 

Brazil is a member of the Common Market of the South (Mercosur), a trade bloc including Argentina, Paraguay, Uruguay, and Venezuela. After the Asian and Russian financial crises, Mercosur adopted a protectionist stance to guard against exposure to the volatility of foreign markets. Brazil and its Mercosur partners have pledged to open the bloc to more trade and investment, but changes require approval of all five members, which makes policy adjustments too difficult to enact.

 

Source : CIA

 

 


Company name

 

GEMINI INDUSTRIA DE INSUMOS FARMACEUTICOS LTDA

 

 

ADDRESSES

 

MAIN ADDRESS:

RUA VP 4D - S/Nº, QUADRA,8 -A - MÓDULOS I E II - DISTRITO AGROINDUSTRIAL DE ANÁPOLIS 

ZIP CODE/CITY:

75132-105 - ANÁPOLIS/GO

 

 

PHONE:

62 3701-5477

E-MAIL:

financeiro@purifarma.com.br

WEB SITE:

www.purifarma.com.br

 

 

 

 

 

ORRECT ADDRESS:

THE CORRECT ADDRESS IS STATED AT THE CAPTION.

 

 

 

BRANCHES:

 

 

 

ADDRESS:

RUA FAUSTINO NEGRI,285 GALPÃO 05 - COOPERATIVA

ZIP CODE/CITY:

09851-720 SÃO BERNARDO DO CAMPO/SP

CNPJ:

10.690.195/0002-83

 

 

ADDRESS:

RUA CORONEL CABRITA,137 - JARDIM DA GLÓRIA

ZIP CODE/CITY:

01545-030 SÃO PAULO/SP

CNPJ:

10.690.195/0003-64

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

Manufacture, import and distribution of pharmaceutical products.

 

LEGAL FORM:

Limited Liability Company

 

 

INCORPORATION DATE:

23/01/2009

REGISTER DATE:

12/03/2009

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

10.690.195/0001-00

STATE REGISTER:

10.450.596-6

 

 

SHARE CAPITAL:

R$ 22.140.000,00

LAST REGISTER OF CAPITAL:

27/07/2017

 

BOARD OF DIRECTORS:

 

 

 

JÚLIO TOMIZO TANAKA

MANAGING PARTNER

VALDETE VIODRES TANAKA

MANAGING PARTNER

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

JÚLIO TOMIZO TANAKA

R$ 11.070.000,00

VALDETE VIODRES TANAKA

R$ 11.070.000,00

 

AFFILIATES / SUBSIDIARIES:

 

A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING UNCONFIRMED HOLDINGS:

 

 

TONICAR AUTO POSTO LTDA

 

J. V. T. - CONSTRUTORA E INCORPORADORA LTDA.

 

LVA PARTICIPAÇÕES LTDA.

 

PP LVA PARTICIPACOES LTDA

 

LEPUGE INSUMOS FARMACEUTICOS LTDA

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JANUARY 23, 2009 TO BE ENGAGED IN THE SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

THE COMPANY OPERATES WITH THE TRADE NAME "PURIFARMA".

 

THE CONTACTS WITH THE SUBJECT WERE MADE THROUGH THE COMPANY OF THE GROUP "LEPUGE INSUMOS FARMACEUTICOS LTDA" LOCATED AT RUA CORONEL CABRITA, 131, SÃO PAULO - SP, CEP 01545-030. CNPJ 57.884.835/0002-50. PHONE 11 2067-5600.

 

PARTNERS:

 

JÚLIO TOMIZO TANAKA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG 11.005.913 SSP/SP AND CPF 006.297.068-24, RESIDENTIAL ADDRESS AT RUA ALAMEDA DAS PRIMAVERAS 255, CONDOMINIO BOUGUEVILLE II - PERUÍBE/SP.

 

VALDETE VIODRES TANAKA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG 15.652.513 SSP/SP AND CPF 075.619.338-94, RESIDENTIAL ADDRESS AT RUA ALAMEDA DAS PRIMAVERAS 255, CONDOMINIO BOUGUEVILLE II - PERUÍBE/SP.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

1

FEDERAL LAWSUIT

09/08/16

2ª VARA GO-ANAPOLIS

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2016, 31/12/2015 AND 31/12/2014.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2016

31/12/2015

31/12/2014

 

 

 

 

CASH

3.791,12

3.839,21

2.526,67

BANKS

28.439,80

16.592,91

398.833,88

ADVANCES

414.612,47

278.353,79

210.269,54

CLIENTS

11.847.997,80

11.083.269,87

4.890.189,55

RECOVERABLE TAXES

1.803.381,32

826.163,33

1.263.635,22

INVENTORY

20.762.073,00

16.210.266,18

12.030.208,15

INVESTMENTS

1.821.987,25

1.712.962,93

154.636,99

PRE PAID EXPENSES

60.368,50

49.104,75

35.860,27

CHECKS

 

 

7.295,09

OTHER

 

 

96.927,67

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

36.742.651,26

30.180.552,97

19.090.383,03

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

ACCOUNTS RECEIVABLE

 

3.330.000,00

8.960.000,00

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

 

3.330.000,00

8.960.000,00

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

4.822.707,93

3.364.974,10

3.554.769,97

DEFERRED

82.941,65

105.562,13

128.182,61

INTANGIBLE

1.850.326,09

27.235,42

37.555,66

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

6.755.975,67

3.497.771,65

3.720.508,24

 

================

================

================

TOTAL ASSETS

43.498.626,93

37.008.324,62

31.770.891,27

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2016

31/12/2015

31/12/2014

 

 

 

 

SALARIES PAYABLE

241.783,88

127.419,33

144.070,49

SOCIAL OBLIGATIONS

262.698,71

170.123,23

461.294,97

PROVISIONS

531.416,48

110.130,14

 

TAXES & CONTRIBUTIONS

1.529.745,66

972.658,55

767.485,70

ACCOUNTS PAYABLE

342.564,55

227.310,81

307.903,80

SUPPLIERS

10.852.419,08

11.854.037,34

8.213.802,78

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

13.760.628,36

13.461.679,40

9.894.557,74

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

5.227.315,96

3.539.421,59

7.522.574,13

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

5.227.315,96

3.539.421,59

7.522.574,13

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

10.000.000,00

10.000.000,00

10.000.000,00

ACCRUED PROFIT (LOSS)

2.363.748,82

109.493,69

845.420,61

CAPITAL RESERVES

12.146.933,79

9.897.729,94

3.508.338,79

 

----------------

----------------

----------------

TOTAL NET EQUITY

24.510.682,61

20.007.223,63

14.353.759,40

 

================

================

================

TOTAL LIABILITIES

43.498.626,93

37.008.324,62

31.770.891,27

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2016, 31/12/2015 AND 31/12/2014.

( FIGURES ARE IN REAIS ).

 

 

31/12/2016

31/12/2015

31/12/2014

 

 

 

 

GROSS SALES

114.675.634,33

66.409.843,02

52.921.499,64

(-) TAXES ON SALES

17.004.381,73

10.536.085,97

7.748.654,63

 

----------------

----------------

----------------

NET SALES

97.671.252,60

55.873.757,05

45.172.845,01

(-) COST OF SOLD GOODS

68.282.438,96

35.665.182,22

29.326.749,65

 

----------------

----------------

----------------

GROSS PROFIT

29.388.813,64

20.208.574,83

15.846.095,36

OPERATING REVENUE (EXPENSE)

-15.259.259,49

-10.442.643,76

-10.631.189,11

FINANCIAL REVENUE(EXPENSE)

3.667.265,88

3.964.023,57

-1.100.053,67

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

17.796.820,03

13.729.954,64

4.114.852,58

NON-OPERATING RESULT

 

-1.385.500,00

 

CONTRIBUTION/INCOME TAX

-5.269.265,85

-1.995.519,89

-1.658.028,32

 

----------------

----------------

----------------

NET PROFIT (LOSS)

12.527.554,18

10.348.934,75

2.456.824,26

 

MONTHLY SALES

 

  2017

 

 

 

---------------------

 

 

JANUARY

R$ 8.833.967,15

 

 

FEBRUARY

R$ 7.321.597,31

 

 

MARCH

R$ 8.832.457,50

 

 

APRIL

R$ 6.923.844,57

 

 

MAY

 

 

 

JUNE

 

 

 

JULY

 

 

 

AUGUST

 

 

 

SEPTEMBER

 

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 31.911.866,53

 

 

 

RATIOS:

31/12/2016

31/12/2015

31/12/2014

 

QUICK RATIO

1,16

 

1,04

 

,71

 

CURRENT RATIO

2,67

 

2,24

 

1,93

 

ACCOUNTS RECEIVABLE TURNOVER

8,24

TIMES

5,04

TIMES

9,24

TIMES

DAYS' SALES IN RECEIVABLES

43,67

DAYS

71,41

DAYS

38,97

DAYS

INVENTORY TURNOVER

3,29

TIMES

2,20

TIMES

2,44

TIMES

ACCOUNTS PAYABLE PERIOD

57,22

DAYS

119,65

DAYS

100,83

DAYS

RETURN ON ASSETS

2,25

TIMES

1,51

TIMES

1,42

TIMES

SALES TURNOVER ON NET EQUITY

3,98

TIMES

2,79

TIMES

3,15

TIMES

NET WORTH TIE-UP

,20

 

,17

 

,25

 

INDEBTEDNESS

,77

 

,85

 

1,21

 

EQUITY RATIO

56,35

%

54,06

%

45,18

%

WORKING CAPITAL RATIO

167,01

%

124,20

%

92,94

%

GENERAL SOLVENCY

2,29

 

2,18

 

1,82

 

RETURN ON NET EQUITY

51,11

%

51,73

%

17,12

%

RETURN ON SALES (PROFIT MARGIN)

12,83

%

18,52

%

5,44

%

GROSS PROFIT MARGIN

30,09

%

36,17

%

35,08

%

OPERATIONAL RESULT

18,22

%

24,57

%

9,11

%

SALES TURNOVER ON LIABILITIES

7,10

TIMES

4,15

TIMES

4,57

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A GOOD FINANCIAL STANDING. IT SHOWS GOOD LIQUIDITY RATIOS WITH POSITIVE WORKING CAPITAL AMOUNT AND SATISFACTORY LEVEL OF INDEBTEDNESS. IN ADDITION IT IS NOTED HIGH GROWING SALES AND PROFITABILITY.

 

REAL ESTATE:

 

   NOT AVAILABLE

 

VEHICLES:

 

   NOT AVAILABLE

 

MACHINES:

 

   NOT AVAILABLE

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

3388-X / 62 3311-1633

 

BANCO ITAU S/A

 

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

GERMANY AND CHINA.

 

   EXPORTS TO:

DOES NOT EXPORT.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

NOT AVAILABLE.

 

 

 

STAFF:

 

THE COMPANY HAS: 160 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 2009. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES.

 

THE LAWSUIT REPORTED IS NOT RELATED WITH TRADE DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

 

FRIGELAR COMERCIO E DISTRIBUICAO S.A.

 

 

IMPAKTO SIST LIMP DESCART LTDA

 

 

REFRIGERACAO DUFRIO COMERCIO E IMPORTACAO LTDA

 

 

SAETA IND COM ELETROELETRONICO LTDA

 

 

VEDAPACK EMBALAGENS INDUSTRIAIS LTDA

 

 

 

PAYMENT HISTORY:

 

16 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 866.883,00

 

AMOUNT OF INVOICES PAID: 178

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 300.953,00

HIGHEST CREDIT: R$ 300.953,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

1

1

R$ 7.048,08

 

 

FINAL OPINION

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 65.06

UK Pound

1

INR 91.50

Euro

1

INR 79.77

BRL

1

INR 19.43

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

PRI

 

 

Report Prepared by :

TPT

 


 

RATING EXPLANATIONS

 

Credit Rating

 

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.